Related Experiment Video
Updated: Jul 17, 2025

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
Published on: July 3, 2014
Cardiotoxicity of Breast Cancer Chemotherapy
Sacha A Roberts1, William H Frishman1
1From the Department of Medicine, NewYork-Presbyterian/Weill Cornell Medical Center, New York, NY.
Abstract:
Breast cancer is one of the leading causes of malignancy affecting women in the United States. Although many effective treatments are available, most come with notable side effects that providers and patients must take into consideration. Various classes of chemotherapeutic agents, including anthracyclines and human epidermal growth factor receptor-2 antagonists, are known to be toxic to myocardial tissue. In this review article, we discuss what is reported in the literature regarding the cardiotoxicity of these agents as well as how to monitor and prevent cardiac injury and dysfunction.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Cardiomyopathy VI: Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Pericarditis IV: Nursing Management
Cardiomyopathy IV: Restrictive Cardiomyopathy

